CorMedix (CRMD) Return on Capital Employed [ROCE] (2011 - 2026)
CorMedix (CRMD) reported Return on Capital Employed [ROCE] of 25.52% for Q2 2026, down 3.60 percentage points from 29.12% a year earlier.
Powered by 
Analysis
CorMedix (CRMD) Return on Capital Employed [ROCE] (2011 - 2026) Analysis & Trends
For FY2025, CorMedix posted Return on Capital Employed [ROCE] of 50.34%, up 83.91 percentage points from FY2024.
- Return on Capital Employed [ROCE] has a five-year change of +127.61 percentage points (FY2020 to FY2025).
- By year, Return on Capital Employed [ROCE] came in at -33.56% in FY2024 (+47.16 pp), -80.72% in FY2023 (-28.98 pp), -51.75% in FY2022 (+2.99 pp) and -54.74% in FY2021 (+22.53 pp).
- Five-year quarterly Return on Capital Employed [ROCE] spans a low of -112.32% in Q2 2024 and a high of 29.12% in Q2 2025.
- Year over year, Return on Capital Employed [ROCE] gained in five of the last seven quarters, with an average year-over-year change of +59.43 percentage points.
- The high point for year-over-year Return on Capital Employed [ROCE] in five years was Q2 2025 (a gain of 141.43 percentage points); the low point was Q3 2024 (a drop of 41.01 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.86% |
| 10 | CorMedix | 558.43 Mn | -94.09 Mn | 77.13 Mn | 25.52% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 25.52% |
| Dec 31, 2025 | 24.44% |
| Sep 30, 2025 | 28.24% |
| Jun 30, 2025 | 29.12% |
| Mar 31, 2025 | 14.50% |
| Dec 31, 2024 | -34.73% |
| Sep 30, 2024 | -103.63% |
| Jun 30, 2024 | -112.32% |
| Mar 31, 2024 | -83.42% |
| Dec 31, 2023 | -64.98% |
| Sep 30, 2023 | -62.62% |
| Jun 30, 2023 | -75.22% |
| Mar 31, 2023 | -61.84% |
| Dec 31, 2022 | -54.93% |
| Sep 30, 2022 | -50.15% |
| Jun 30, 2022 | -51.77% |
| Mar 31, 2022 | -46.71% |
| Dec 31, 2021 | -44.05% |
| Sep 30, 2021 | -38.05% |
| Jun 30, 2021 | -32.46% |
API Access
CorMedix Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=CRMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "CRMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=CRMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();